Laser treatment of acne conglobate with concomitant oral isotretinoin use |
Molecule Updates
eMediNexus Coverage from: 
Laser treatment of acne conglobate with concomitant oral isotretinoin use
eMediNexus,  17 December 2020
Coronavirus Live Count Map India

remove_red_eye 728 Views
COVID-19 Vaccine Updates

#Dermatology

0 Read Comments                

Systemic isotretinoin is frequently used in patients with severe and persistent acne. In a case report, a stable remission of inflammation, aesthetic correction of scars, and a positive impact on the psychological status and social adaptation resulted from 2-years of treatment of the patient with systemic isotretinoin and laser treatment plan. At the first stage, a course of vascular laser Nd: YAP/KTP 1079/540 nm in areas with a tendency to hypertrophic growth on the face and neck; at the second stage, the use of the Er:YAG laser 2940 nm with SMA technology for all type’sscars.

Following four sessions using the vascular laser with an interval of 2-3 weeks led to a clinical efficacy which was reflected in the elimination of itching, the reduction of the scar density, decrease of vascularization. Following two years of treatment of the patient with severe widespread acne conglobata with the resistant course, the DLQI decreased from 24 (extreme effect on the quality of life) to 6 (moderate effect).

Resource: Kalashnikova NG, Igorevna AV, Mohammad J. Laser treatment of acne conglobata with concomitant oral isotretinoin use. Dermatologic therapy. 2020; DOI: 10.1111/dth.14553Accessed fromhttps://pubmed.ncbi.nlm.nih.gov/33205848/

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now